Perle Bioscience, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-05-18
- Employees
- 11
- Market Cap
- -
- Website
- http://perlebioscience.com
The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes
Phase 3
Withdrawn
- Conditions
- Type 1 Diabetes
- Interventions
- Drug: Oral Cyclosporine and Oral LansoprazoleDrug: Placebos
- First Posted Date
- 2013-01-08
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Perle Bioscience, Inc.
- Registration Number
- NCT01762657
The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
Phase 3
Withdrawn
- Conditions
- Type 1 Diabetes
- Interventions
- First Posted Date
- 2013-01-08
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Perle Bioscience, Inc.
- Registration Number
- NCT01762644
© Copyright 2025. All Rights Reserved by MedPath